Search

everythinglearnresearchcommunity

for

Search:↓

Serum AMH levels are a strong marker for diagnosing PCOS in Indian women.

PCOS is a genetic disorder affecting women's reproductive health, with treatments focused on symptoms like insulin resistance and fertility.

Women with hair loss have higher androgen levels, while men with early balding have altered androgen ratios.

Lifestyle changes and weight loss are key for treating PCOS-related metabolic issues and infertility, with various medications available for specific symptoms.

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.

Metformin helps regulate menstrual cycles, induce ovulation, and improve pregnancy outcomes in women with PCOS.

Obesity changes androgen levels in women with PCOS, leading to higher testosterone relative to androstenedione.

The 2023 guideline for PCOS suggests using updated diagnostic criteria, assessing related health risks, and recommends lifestyle changes and specific treatments for symptoms and fertility issues.

PCOS is a hormonal disorder causing symptoms like excess hair, acne, irregular periods, and fertility issues.

COVID-19 may cause hair loss, often after recovery, with androgenetic alopecia being the most common type.

The article concludes that better diagnosis and management of Polycystic Ovarian Syndrome are needed to improve women's health and prevent related diseases.

Vitamin D supplements increased ovulation rates in women with PCOS who were vitamin D deficient.

After chemotherapy for a gestational trophoblastic tumor, normal pregnancy rates are possible, but there's a slightly higher risk of the tumor reoccurring in future pregnancies.

Postmenopausal ovary stromal cells have a unique makeup and limited steroid production, suggesting androgens come from the adrenal gland.

The document concludes that insulin resistance is key in PCOS development and early treatment is crucial to prevent complications.

Antiandrogens, particularly flutamide and CPA, are most effective for treating hirsutism, with long-term use needed for best results.

The conclusion is that androgen receptor gene polymorphism might be a marker for polycystic ovary syndrome, but more research is needed.

Diagnosing PCOS in teenagers should focus on signs of excess male hormones and not rely solely on ovarian ultrasound or irregular periods, and should be reassessed in adulthood.

Isotretinoin improves severe acne without changing androgen or insulin levels but may increase body weight and triglycerides.

A teenage girl had both a rare ovarian tumor and a severe form of polycystic ovarian syndrome.

The conclusion is that lifestyle changes and weight loss are first-line treatments for infertility due to anovulation, with various medications and assisted reproductive technologies as additional options.

PCOS often causes skin issues like excess hair, acne, and hair loss, needing early treatment.

White hirsute women with PCOS have higher insulin resistance, but similar nitric oxide and fibrinogen levels compared to those with idiopathic hirsutism.

Ustekinumab significantly improved sexual function and quality of life for people with moderate to severe psoriasis.

Methotrexate treatment for rheumatoid arthritis has a serious infection rate of about two per 100 patient-years.

Flutamide worked better than finasteride for reducing excessive hair growth in women, but had more side effects.

Lower nitric oxide and higher fibrinogen found in hirsute women; impaired sexual function in 22.6% of hair loss patients, linked to psoriasis severity.

The 2003 consensus updated PCOS diagnosis criteria and linked PCOS to higher risks of diabetes and heart problems, recommending lifestyle changes to lower these risks.

Most women with excess male hormones have Polycystic Ovary Syndrome, and hormonal therapy can improve symptoms but may cause side effects.

Polycystic ovary syndrome costs the U.S. over $4 billion a year, mainly from treating related health issues.